Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 1
2012 1
2013 1
2014 5
2015 1
2016 2
2017 4
2018 5
2019 2
2020 6
2021 2
2022 4
2023 2
2024 3
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 Free article. No abstract available.
Adrenocortical carcinoma: Single center experience.
Şişman P, Şahin AB, Peynirci H, Cander S, Gül ÖÖ, Ertürk E, Ersoy C. Şişman P, et al. Among authors: gul oo. Turk J Urol. 2017 Dec;43(4):462-469. doi: 10.5152/tud.2017.81598. Epub 2017 Dec 1. Turk J Urol. 2017. PMID: 29201509 Free PMC article.
Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study.
Zuhur SS, Ozturk BO, Keskin U, Uysal S, Hacioglu A, Avci U, Karsli S, Andac B, Ozbay UN, Kilinc F, Erol S, Catak M, Sodan H, Pekkolay Z, Burhan S, Akbaba G, Ates C, Yorulmaz G, Tekin S, Topcu B, Tuna MM, Kadioglu P, Gonen MS, Karaca Z, Ciftci S, Celik M, Guldiken S, Tuzun D, Altuntas Y, Akturk M, Niyazoglu M, Cinar N, Gul OO, Kebapci MN, Akalin A, Bayraktaroglu T, Elbuken G. Zuhur SS, et al. Among authors: gul oo. Endocrine. 2024 Sep;85(3):1300-1309. doi: 10.1007/s12020-024-03809-0. Epub 2024 Apr 3. Endocrine. 2024. PMID: 38570387
How the COVID-19 outbreak affected patients with diabetes mellitus?
Sisman P, Polat I, Aydemir E, Karsi R, Gul OO, Cander S, Ersoy C, Erturk E. Sisman P, et al. Among authors: gul oo. Int J Diabetes Dev Ctries. 2022 Jan;42(1):53-61. doi: 10.1007/s13410-021-00992-y. Epub 2021 Sep 10. Int J Diabetes Dev Ctries. 2022. PMID: 34539126 Free PMC article.
Clinical characteristics, mid-term outcomes and management of asymptomatic primary hyperparathyroidism: A multicentre retrospective cohort study.
Engin İ, Tuna MM, Köroğlu EY, Çakır B, Fırat SN, Yağcı H, Bahadır ÇT, Kır Y, Gülçelik NE, Karahan A, Gürkan E, Yeşiltepe A, Cansu GB, Sakar K, Çınar N, Güneş Ş, Üzüm AK, Candemir DK, Kılınç F, Özbay ÜN, Oğuz A, Güven M, Koca AO, Görgel A, Baldane S, Boz O, Uçan B, Güneş E, Taban S, Fenkçi SM, Çalapkulu M, Aydemir M, Sarı R, Tufan C, Saygılı ES, Üç ZA, Duran C, Basmacı N, Gürlek A, Konak YYU, Bilginer C, Kimyon ÖŞ, Bozkur E, Uzun Ö, Elbüken G, Karatoprak K, Gül ÖÖ, Canpolat AG, Şahin M. Engin İ, et al. Among authors: gul oo. Endocrine. 2025 Aug 12. doi: 10.1007/s12020-025-04380-y. Online ahead of print. Endocrine. 2025. PMID: 40790100
44 results